logo
Wuhan Desheng Biochemical Technology Co., Ltd
Wuhan Desheng Biochemical Technology Co., Ltd
news
Home / news /

Company News About The 2025 CMEF has come to a successful conclusion, with a wonderful review of Hubei Xindesheng.

The 2025 CMEF has come to a successful conclusion, with a wonderful review of Hubei Xindesheng.

2025-04-11
The 2025 CMEF has come to a successful conclusion, with a wonderful review of Hubei Xindesheng.

The 91st China International Medical Equipment Fair (CMEF) will be held grandly at the Shanghai National Convention and Exhibition Center from April 8th to 11th, 2025. This annual industry event, with its exhibition area of 300000 square meters, a large lineup of over 5000 exhibitors, and a rich agenda of more than 50 conferences and forums, has become an important platform for medical and health technology exchange and display at home and abroad. CMEF has successfully concluded on April 11th. Let's take a look back at the wonderful moments of Hubei Xindesheng Material Technology Co., Ltd. at this exhibition.


New Desheng's full range of products shines at CMEF


1. Biological buffer series: Maintaining a stable pH environment is crucial in biological experiments and in vitro diagnostic reagent production. Xindesheng has a rich and diverse range of biological buffer products, with dozens of categories to choose from, which can meet the needs of different experimental and production scenarios. Its daily output can reach 5 tons, and its strong production capacity ensures the stability of market supply. The product has the advantages of high purity and stable process, and can also be customized according to customer specifications.


2. Color substrate series: New Desheng's color substrate products stand out for their high purity, high water solubility, color stability, and multi scene adaptability. On the basis of a wide range of available colorants, the detection system can be optimized to support multiple substrate detections with high detection sensitivity.


3. Luminescent reagent series: Chemiluminescent reagents are widely used in the field of in vitro diagnostics. New Desheng's products such as luminol, isoluminol, and acridine esters have reached analytical purity levels, with high purity and few impurities. In chemiluminescence reactions, these reagents can stably function with high luminescence efficiency and fast reaction speed. Among them, acridine ester has 7 different functional groups, which can meet the diverse needs of customers for immunological analysis and other experiments.


4. Enzyme preparation series: Xindesheng's enzyme preparations have the characteristics of high activity and stability. Through a strict quality control system, the consistency of each batch of products is ensured. Its products widely cover multiple testing items such as cardiovascular markers, infectious disease screening, and cancer diagnosis.


5. Blood collection tube reagent series: As a well-established manufacturer of a complete set of blood collection tube additives, Xindesheng has rich experience in research and development and production. Its product range is complete, the process is mature, and the quality is stable and reliable. Whether it is blood collection reagents such as coagulants, anticoagulants, or separation gels, Xindesheng can provide full category coverage and can be deeply customized according to customer needs, with agile response.


In depth negotiations to jointly build a bridge of cooperation


1. Extensive collection of cooperation intentions: During the CMEF exhibition, the New Desheng booth at 8.2ZA31 attracted industry professionals from all over the world. Professional personnel always stick to their posts and warmly receive every visiting customer. Through in-depth communication, gain a multi-dimensional understanding of the customer's business needs, pain points, and future development plans. Many customers have shown strong interest in the application of New Desheng's biological buffer and enzyme preparation raw material products in research and development. During the exhibition, multiple potential cooperation intentions were collected from different regions and fields, laying a solid foundation for future business expansion.


2. Preliminary achievement of cooperation results: After several days of active negotiations, Xindesheng achieved fruitful cooperation results at the exhibition. We have signed strategic cooperation framework agreements with multiple well-known domestic and foreign medical device companies, covering multiple product fields such as luminescent reagents, chromogenic substrates, enzyme preparations, etc. Among them, a long-term cooperation has been established with an overseas in vitro diagnostic enterprise for the supply of biological buffer agents, and Xindesheng will provide customized buffer products for it. These collaborative achievements not only reflect the quality and technical strength of New Desheng's products, but also further enhance the company's visibility and influence in overseas markets. After the negotiations, many customers expressed that Xindesheng's professional team, full range of product lines, and stable supply capabilities make it an ideal partner for cooperation.


New Desheng's Corporate Strength and Development Prospects


Hubei Xindesheng Material Technology Co., Ltd. was founded in 2005. After 20 years of steady development, it has become a technology enterprise mainly engaged in research and development, production, sales, and service of blood test pre-processing reagents, in vitro diagnostic reagent raw materials, and biological buffering agents. The company ensures reliable and stable product quality through continuous technological innovation and strict quality control system, and has successfully passed the ISO9001 quality management system certification. With a strong production capacity of 5000 tons per year, it is able to provide stable product supply to customers, while also undertaking commissioned customization services and mass production services to meet the diverse needs of different customers.


At the CMEF exhibition, Xindesheng fully demonstrated its corporate strength and product advantages, attracting the attention and communication of many industry professionals. Looking ahead to the future, Xindesheng will continue to uphold the development philosophy of innovation driven and quality first, continuously increase research and development investment, improve product quality and service level, and continue to deepen its cultivation in the field of in vitro diagnostic reagent raw materials, working hand in hand with customers to create a better future.


Thank you again to every friend who met Xindesheng at the 2025 CMEF exhibition. We look forward to meeting again in the future to explore new opportunities for industry development and contribute to the progress of the medical and health industry.